Back
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedi...
Liminatus Pharma, Inc. Class A Common Stock LIMN · Transcripts
Price2.71
Market Cap3.41 M
Float995.71 K
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents